{"schema":"hottub-news/story/v1","story":"st_4ziwswwqbhij2xrqon3a","title":"Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/tarsus-plans-to-present-11-abstracts-highlighting-new-insights-in-4ziwswwqbh","count":1,"items":[{"id":"n_4ziwswwqbhij2xrqon3a","seq":671240,"kind":"press_release","title":"Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting","url":"https://www.globenewswire.com/news-release/2026/09/29/3370836/0/en/tarsus-plans-to-present-11-abstracts-highlighting-new-insights-in-demodex-blepharitis-ocular-rosacea-and-the-real-world-impact-of-xdemvy-at-the-american-academy-of-optometry-2026-a.html","summary":"IRVINE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that it expects to present 11 scientific abstracts at the American Academy of Optometry (AAOpt) 2026 Annual Meeting, taking place Sept. 30–Oct. 3 in Anaheim, California.","published":"2026-09-29T12:30:00Z","seen":"2026-09-29T12:44:28Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nasdaq:tars","us87650l1035"],"entities":[{"id":"Q134287","name":"Tarsus","type":"org"},{"id":"Q4742899","name":"American Academy of Optometry","type":"org"}],"story":"st_4ziwswwqbhij2xrqon3a","category":"science-technology","category_p":0.3100000023841858,"category2":"health","sentiment":"neutral","tone":0.07000000029802322,"political":0.09000000357627869}]}